Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
EUR/USD: Lagarde’s dovish tilt weighs on Euro – ING

EUR/USD: Lagarde’s dovish tilt weighs on Euro – ING

FXStreetFXStreet2026/09/29 07:42

Francesco Pesole at ING says EUR/USD downside risks have increased after dovish comments from European Central Bank (ECB) President Christine Lagarde, which widened SOFR-ESTR spreads and tempered expectations for an October ECB hike.

Lagarde comments pressure Euro outlook

"The euro held up relatively well yesterday considering the slew of dovish-leaning comments by ECB President Lagarde, which favoured a widening in the SOFR-ESTR 2yr swap to beyond 155bp. We are now not far from the 163bp max width reached in early July."

"Lagarde seemed willing to tone down some market enthusiasm about an October hike yesterday, saying that tight financial conditions are limiting the pass-through of energy costs to the broader economy. She also stressed that the ECB should adopt a “measured response” given no evidence of second-round effects."

"Her remarks confirm our suspicion that if one central bank hikes in October, it will be the Fed, and not the ECB. Pricing is now 17bp and 9bp, respectively. Our macro team thinks both will wait until December, hence our baseline view for a higher EUR/USD by year-end."

"But any hint of strong US data could prompt a test of the 1.1320-30 summer lows, with Lagarde’s comments lifting some support off the euro."

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AstraZeneca (AZN.US) invests in Summit (SMMT.US), gaining positive outlooks from JPMorgan and Citi: Cancer drug strategy awaits validation

Analysts from JPMorgan and Citi have welcomed the deal between AstraZeneca and Summit Therapeutics, stating that it aligns with AstraZeneca's cancer strategy.

智通财经•2026/09/29 11:06

The United States relaxes fuel standards, significantly reducing technology costs for automakers: General Motors (GM.US) is expected to save 20.4 billion dollars, and the price per vehicle may drop by nearly 1,300 dollars.

The United States has relaxed fuel economy standards, allowing automakers to save $60.6 billions in technology costs by 2031, with the cost per vehicle expected to decrease by $1,289.

智通财经•2026/09/29 11:02